IMPORTANT INVESTOR ALERT: Khang & Khang LLP Announces Securities Class Action Lawsuit Against Alere Inc. And Encourages Investors With Losses To Contact The Firm

Khang & Khang LLP (the "Firm") announces the filing of a class action lawsuit against Alere Inc. ("Alere" or the "Company") (NYSE: ALR). Investors who purchased or otherwise acquired shares between February 29, 2012 and November 4, 2016 inclusive (the "Class Period"), are encouraged to contact the Firm in advance of the January 13, 2017 lead plaintiff motion deadline.

If you purchased shares of Alere during the Class Period, please contact Joon M. Khang, Esquire, of Khang & Khang LLP, 18101 Von Karman Avenue, 3rd Floor, Irvine, CA 92612, by telephone: (949) 419-3834, or by e-mail at joon@khanglaw.com.

There has been no class certification in this case. Until certification occurs, you are not represented by an attorney. You may choose to take no action and remain a passive class member.

The complaint alleges that Alere made false and misleading statements and/or failed to disclose: that the Company's wholly-owned subsidiary, Arriva Medical, LLC ("Arriva"), was submitting claims to Medicare for deceased patients; that this conduct subjected Arriva to revocation of its Medicare enrollment; and that as a result of the above, Alere's statements about its business, operations, and prospects, were false and misleading and/or lacked a reasonable basis at all relevant times. On November 4, 2016, Alere announced that the Centers for Medicare and Medicaid Services alleged that Arriva submitted claims for 211 deceased patients over a five-year period, and thus revoked Arriva's Medicare enrollment. When this information was disclosed, shares of Alere declined in value, causing investors harm.

If you wish to learn more about this lawsuit at no charge, or if you have any questions regarding this notice or your rights, please contact Joon M. Khang, a prominent litigator for almost two decades, by telephone: (949) 419-3834, or by e-mail at joon@khanglaw.com.

This press release may constitute Attorney Advertising in some jurisdictions.

If you liked this article you might like

These Stocks Are Ready to Reverse Course

Abbott CEO: Another Alere-Related Divestiture Coming Soon

Alere, St. Jude Deals in Focus as Abbott Releases Q2 Earnings

Quidel Diversifies With Alere's Triage Assets

Alere Shareholders Vote to Approve Amended Merger with Abbott